189 related articles for article (PubMed ID: 33401721)
21. Proteome profiling of the prefrontal cortex of Fmr1 knockout mouse reveals enhancement of complement and coagulation cascades.
Gao MM; Shi H; Yan HJ; Long YS
J Proteomics; 2023 Mar; 274():104822. PubMed ID: 36646274
[TBL] [Abstract][Full Text] [Related]
22. Inefficient thermogenic mitochondrial respiration due to futile proton leak in a mouse model of fragile X syndrome.
Griffiths KK; Wang A; Wang L; Tracey M; Kleiner G; Quinzii CM; Sun L; Yang G; Perez-Zoghbi JF; Licznerski P; Yang M; Jonas EA; Levy RJ
FASEB J; 2020 Jun; 34(6):7404-7426. PubMed ID: 32307754
[TBL] [Abstract][Full Text] [Related]
23. Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency.
Conca Dioguardi C; Uslu B; Haynes M; Kurus M; Gul M; Miao DQ; De Santis L; Ferrari M; Bellone S; Santin A; Giulivi C; Hoffman G; Usdin K; Johnson J
Mol Hum Reprod; 2016 Jun; 22(6):384-96. PubMed ID: 26965313
[TBL] [Abstract][Full Text] [Related]
24. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
[TBL] [Abstract][Full Text] [Related]
25. Agmatine relieves behavioral impairments in Fragile X mice model.
Jeon SJ; Kwon H; Bae HJ; Gonzales EL; Kim J; Chung HJ; Kim DH; Ryu JH; Shin CY
Neuropharmacology; 2022 Nov; 219():109234. PubMed ID: 36057317
[TBL] [Abstract][Full Text] [Related]
26. Abnormal development of auditory responses in the inferior colliculus of a mouse model of Fragile X Syndrome.
Nguyen AO; Binder DK; Ethell IM; Razak KA
J Neurophysiol; 2020 Jun; 123(6):2101-2121. PubMed ID: 32319849
[TBL] [Abstract][Full Text] [Related]
27. Converging purinergic and immune signaling pathways drive IL-6 secretion by Fragile X cortical astrocytes via STAT3.
Reynolds KE; Krasovska V; Scott AL
J Neuroimmunol; 2021 Dec; 361():577745. PubMed ID: 34695768
[TBL] [Abstract][Full Text] [Related]
28. Decreased surface expression of the δ subunit of the GABA
Zhang N; Peng Z; Tong X; Lindemeyer AK; Cetina Y; Huang CS; Olsen RW; Otis TS; Houser CR
Exp Neurol; 2017 Nov; 297():168-178. PubMed ID: 28822839
[TBL] [Abstract][Full Text] [Related]
29. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.
Bilousova TV; Dansie L; Ngo M; Aye J; Charles JR; Ethell DW; Ethell IM
J Med Genet; 2009 Feb; 46(2):94-102. PubMed ID: 18835858
[TBL] [Abstract][Full Text] [Related]
30. Regional brain volumes changes in adult male FMR1-KO mouse on the FVB strain.
Lai JK; Lerch JP; Doering LC; Foster JA; Ellegood J
Neuroscience; 2016 Mar; 318():12-21. PubMed ID: 26794591
[TBL] [Abstract][Full Text] [Related]
31. Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse.
Higashimori H; Morel L; Huth J; Lindemann L; Dulla C; Taylor A; Freeman M; Yang Y
Hum Mol Genet; 2013 May; 22(10):2041-54. PubMed ID: 23396537
[TBL] [Abstract][Full Text] [Related]
32. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
[TBL] [Abstract][Full Text] [Related]
33. Enhanced asynchronous Ca(2+) oscillations associated with impaired glutamate transport in cortical astrocytes expressing Fmr1 gene premutation expansion.
Cao Z; Hulsizer S; Cui Y; Pretto DL; Kim KH; Hagerman PJ; Tassone F; Pessah IN
J Biol Chem; 2013 May; 288(19):13831-41. PubMed ID: 23553633
[TBL] [Abstract][Full Text] [Related]
34. Astrocyte-secreted thrombospondin-1 modulates synapse and spine defects in the fragile X mouse model.
Cheng C; Lau SK; Doering LC
Mol Brain; 2016 Aug; 9(1):74. PubMed ID: 27485117
[TBL] [Abstract][Full Text] [Related]
35. Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome.
Lovelace JW; Rais M; Palacios AR; Shuai XS; Bishay S; Popa O; Pirbhoy PS; Binder DK; Nelson DL; Ethell IM; Razak KA
Cereb Cortex; 2020 Mar; 30(3):969-988. PubMed ID: 31364704
[TBL] [Abstract][Full Text] [Related]
36. Cerebellar contribution to autism-relevant behaviors in fragile X syndrome models.
Gibson JM; Vazquez AH; Yamashiro K; Jakkamsetti V; Ren C; Lei K; Dentel B; Pascual JM; Tsai PT
Cell Rep; 2023 Dec; 42(12):113533. PubMed ID: 38048226
[TBL] [Abstract][Full Text] [Related]
37. The loss of β adrenergic receptor mediated release potentiation in a mouse model of fragile X syndrome.
García-Font N; Martín R; Torres M; Oset-Gasque MJ; Sánchez-Prieto J
Neurobiol Dis; 2019 Oct; 130():104482. PubMed ID: 31129085
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.
Curia G; Papouin T; Séguéla P; Avoli M
Cereb Cortex; 2009 Jul; 19(7):1515-20. PubMed ID: 18787232
[TBL] [Abstract][Full Text] [Related]
39. The newborn Fmr1 knockout mouse: a novel model of excess ubiquinone and closed mitochondrial permeability transition pore in the developing heart.
Barajas M; Wang A; Griffiths KK; Matsumoto K; Liu R; Homma S; Levy RJ
Pediatr Res; 2021 Feb; 89(3):456-463. PubMed ID: 32674111
[TBL] [Abstract][Full Text] [Related]
40. Altered cortical Cytoarchitecture in the Fmr1 knockout mouse.
Lee FHF; Lai TKY; Su P; Liu F
Mol Brain; 2019 Jun; 12(1):56. PubMed ID: 31200759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
